论文部分内容阅读
目的探讨纳络酮与小剂量甘露醇联合治疗COPD并发肺性脑病的疗效。方法将确诊为COPD并发肺性脑病的55例患者,随机分为治疗组(用纳洛酮+甘露醇治疗)30例和对照组(用常规方法治疗)25例,观察治疗前后患者临床症状改善变化情况以评定疗效。结果治疗组总有效率为86.7%,对照组为64.0%,两组比较差异有统计学意义(P<0.05),在治疗过程中无不良反应发生。结论纳洛酮与小剂量甘露醇治疗早期肺性脑病疗效确切、安全。
Objective To investigate the curative effect of naloxone combined with low-dose mannitol in the treatment of pulmonary encephalopathy in COPD patients. Methods Fifty-five patients diagnosed as COPD complicated with pulmonary encephalopathy were randomly divided into treatment group (naloxone + mannitol treatment) and control group (25 cases), and the clinical symptoms were observed before and after treatment Changes to assess the efficacy. Results The total effective rate was 86.7% in the treatment group and 64.0% in the control group. There was significant difference between the two groups (P <0.05). No adverse reactions occurred during the treatment. Conclusion Naloxone and low-dose mannitol in the treatment of early pulmonary encephalopathy is effective and safe.